slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
223,681-223,710 of 319,975
03
Uses an infinity loop diagram to represent a continuous process or cycle of learning.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Interest1 hit
04
The slide highlights the pharmacodynamic (PD) effect of background corticosteroids in the placebo group, which was unexpected.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · InterestLoop · Aha Moment1 hit
05
The slide uses a circular portrait montage to humanize the 'transformation' message.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide outlines a clinical trial protocol using a process flow diagram.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations 1 hit
07
The slide presents a clinical trial outcome summary for the ADDRESS study.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Satisfaction1 hit
08
The slide uses a process-oriented visual layout to map strategic pillars to specific operational achievements.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Satisfaction1 hit
09
The slide uses a background image of the ocean with a digital network overlay, typical of biotech corporate branding.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Desire1 hit
01
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
02
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
03
The slide uses a structured list format to present key company pillars.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
04
Uses a two-column comparison for Sepsis vs Septic Shock, followed by two rows of key metrics.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a process flow diagram to contrast time-to-diagnosis and a bar chart to illustrate the exponential mortality risk of delayed treatment.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
Uses a before-after-bridge framing to contrast current lab processes with the proposed solution.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The slide uses a two-column layout to contrast the platform hardware with the consumable cartridges.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a problem-solution framing, identifying the biomarker's potential and the specific pain point (time-sensitivity) that the Symphony IL-6 assay solves.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide highlights the superior NPV of IL-6 compared to standard biomarkers using a table and an ROC curve.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a horizontal bar chart to represent progress through Research, Development, Clinical Testing, and Regulatory stages.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
The slide emphasizes the clinical value of rapid turnaround time in critical care settings.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Includes a specific capital requirement estimate at the bottom.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
13
The slide uses a bottom-up market sizing approach based on patient volumes and testing frequency.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
14
The table compares 7 distinct operational metrics between the Bluejay Symphony and competitors (Beckman, Siemens, Roche).Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
15
Uses a stepped growth diagram to illustrate the commercialization roadmap.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
16
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
17
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
18
Includes both internal cash position and public market trading data for BJSX.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · Financial Highlights1 hit
19
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
20
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
01
Comera | Investor Presentation Deck | 16 slidesComera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations 1 hit
02
Comera | Investor Presentation Deck | 16 slidesComera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations 1 hit
03
Comera | Investor Presentation Deck | 16 slidesComera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations 1 hit